A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors
about
Lost in translation: pluripotent stem cell-derived hematopoiesisHematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitroModeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome EngineeringRobust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditionsHuman pluripotent stem cells: an emerging model in developmental biology.Secreted cerberus1 as a marker for quantification of definitive endoderm differentiation of the pluripotent stem cells.The Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone DisordersPluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus.Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem CellsTrisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cellsThe hematopoietic system in the context of regenerative medicine.Generation of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method.Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion.Mesodermal and hematopoietic differentiation from ES and iPS cells.Prospects and challenges of reprogrammed cells in hematology and oncology.Engineering the human pluripotent stem cell microenvironment to direct cell fate.Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells.From stem cells to red blood cells: how far away from the clinical application?Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis.Ex vivo Generation of Genetically Modified Macrophages from Human Induced Pluripotent Stem Cells.Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells.Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.A portable platform for stepwise hematopoiesis from human pluripotent stem cells within PET-reinforced collagen sponges.A defined culture method enabling the establishment of ring sideroblasts from induced pluripotent cells of X-linked sideroblastic anemia.Identification of a High-Frequency Somatic NLRC4 Mutation as a Cause of Autoinflammation by Pluripotent Cell-Based Phenotype Dissection.
P2860
Q26801840-B24396A7-979D-4E29-B686-C3C87A098FA5Q26851475-32E3CDE6-232C-457E-880F-052BFDBD0F91Q27324593-DCFB6B8B-5AAB-447F-AD75-FF689D30B984Q28083303-304FA46F-D3B2-4C7A-915A-5A449816E380Q28485950-90D1E385-F903-42B6-9EE5-5A5CE23B0DAAQ34325210-922E90C9-4DAC-4D8B-8D51-E8C41584CDFDQ34745578-6CA52907-BF62-49FC-94B5-25A8EFC66618Q34990691-78DFF38D-15DC-4A4D-9897-15388E4524BAQ35183911-D63DE7FD-4AB5-480F-B857-0F0F64A2397CQ36182364-296400CA-7A24-450A-9469-64EECD46E4C7Q36378400-DBDD349B-4C51-43E5-A59F-0FC4497122B3Q36627127-5A7664C5-B703-42F5-A4BD-1A643BF49D6EQ37740413-5F256902-C336-486D-B516-88564764CC27Q38014779-2AE483A1-7D8A-42C9-A1BF-B7B3A4BC5E17Q38017612-119CA925-6260-4177-9F5C-58444869B3C0Q38031618-DB25A6C0-E5B7-4CB7-B734-042D3D040ADEQ38091202-73E77506-672E-4ED5-A25C-CDB8FBC868ACQ38116641-CDFD5FD0-46B6-41F0-A947-C0AD887C90CBQ38211827-3FBC2702-2F16-4078-AC70-E2419E03C68FQ39105427-FB435260-9280-4B2E-9BE3-DD29C5AEC908Q40155273-E44C89FC-FAE1-42FE-8B31-EE9C799E8BC4Q41242710-50BA8994-57D8-4925-8398-DD9F4728E830Q41644327-6B02B0C1-F196-43BD-AF18-A0961B80AC90Q42046446-75084FD3-1B54-4B4F-B309-EF884DB0C70FQ48367908-3C48BC74-7845-4A62-85EF-04C42B5ED9EEQ50118902-F9B0A74F-90A1-4F56-9546-240150F90773Q51359431-BDB2E40D-A976-48F6-8397-3295FB625143
P2860
A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@ast
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@en
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@nl
type
label
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@ast
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@en
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@nl
prefLabel
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@ast
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@en
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@nl
P2093
P2860
P3181
P1433
P1476
A novel serum-free monolayer c ...... lls via mesodermal progenitors
@en
P2093
Akira Niwa
Hirofumi Suemori
Itaru Kato
Katsutsugu Umeda
Koichi Oshima
Megumu K Saito
Tatsutoshi Nakahata
Toshio Heike
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0022261
P407
P50
P577
2011-01-01T00:00:00Z